Business
Helix BioPharma Corp Achieves Last-Patient-Out in Its Phase II Trial of Topical Interferon Alpha-2b in Patients with Ano-Genital Warts
Helix BioPharma Corp Achieves Last-Patient-Out in Its Phase II Trial of Topical Interferon Alpha-...
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\nAURORA, Ontario, Mar. 22, 2010 (Canada NewsWire Group) -- \n/CNW/ --\n\n\n\n","length":255,"tagName":"div"}]